Paraneoplastic antigens as biomarkers for early diagnosis of ovarian cancer
Paraneoplastic syndromes are a group of rare disorders that can be triggered by an abnormal immune response to proteins from tumors of the lung, ovary, lymphatics, or breast. Paraneoplastic clinical syndromes affect <1% of patients with cancer; however, the frequency of subclinical levels of para...
Saved in:
Main Authors: | Madhumita Chatterjee (Author), Laura C. Hurley (Author), Michael A. Tainsky (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Myasthenia as a paraneoplastic manifestation of ovarian Cancer
by: Marcelo Simonsen, et al.
Published: (2018) -
Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets
by: Kaipeng Xie, et al.
Published: (2019) -
Can Prostate Specific Antigen Be Used as New Biomarker for Early Diagnosis of Breast Cancer?
by: Seyed Mostafa Shiryazdi, et al.
Published: (2015) -
Paraneoplastic cerebellar degeneration in a patient with ovarian cancer
by: Hung-Ju Chien, et al.
Published: (2015) -
Paraneoplastic Disorders and Ovarian Tumors
by: J Gordon Millichap, et al.
Published: (2014)